United States - English - NLM (National Library of Medicine)

xspire pharma, llc - caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e), butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - caffeine 40 mg - butalbital, acetaminophen and caffeine capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. caution in this regard is required because butalbital is habit-forming and potentially abusable. this product is contraindicated under the following conditions: - hypersensitivity or intolerance to any component of this product - patients with porphyria butalbital barbiturates may be habit-forming: tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. the average daily dose for the barbiturate addict is usually about 1500 mg. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fatal dosage, however, does not increase more than two-fold. as this occurs, the margin between an in

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - caffeine citrate - solution for infusion - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - caffeine citrate - oral solution - 10mg/1ml

Malta - English - Medicines Authority

chefaro ireland dac the sharp building, hogan place, dublin 2,, ireland - caffeine, paracetamol, codeine phosphate, hemihydrate - hard capsule - caffeine 30 mg paracetamol 500 mg codeine phosphate hemihydrate 8 mg - analgesics

Canada - English - Health Canada

added dimensions - caffeine - tablet - 200mg - caffeine 200mg - respiratory and cns stimulants

United States - English - NLM (National Library of Medicine)

cvs pharmacy - caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - caffeine 200 mg - alertness aid helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

United States - English - NLM (National Library of Medicine)

cvs pharmacy - caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - caffeine 200 mg - alertness aid helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

United States - English - NLM (National Library of Medicine)

aaa pharmaceutical, inc. - caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - caffeine 200 mg - alertness aid helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - caffeine, quantity: 12.5 mg - oral liquid, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; water for injections - cafnea oral solution is indicated for the short-term treatment of apnoea of prematurity in infants between 28 and 33 weeks gestational age.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - caffeine, quantity: 20 mg - injection, intravenous infusion - excipient ingredients: sodium citrate dihydrate; water for injections; citric acid monohydrate - cafnea injection is indicated for the short-term treatment of apnoea of prematurity in infants between 28 and 33 weeks gestational age.